The Src signaling pathway

A potential target in melanoma and other malignancies

Jade Homsi, Christopher Cubitt, Adil Daud

Research output: Contribution to journalReview article

56 Citations (Scopus)

Abstract

Although Src was the first oncogene to be discovered as the transforming protein of the Rous sarcoma virus almost three decades ago, the role of Src and the Src family kinases in human oncogenesis is still not completely understood. Recent studies have shown that Src regulates cell adhesion, invasiveness and motility in cancer cells and in tumor vasculature, rather than directly influencing cell replication. The role of the Src family kinases in human cancer is evolving and elevated levels of Src kinase activity have been reported in a number of human cancers in vitro and in vivo. Src expression and activity are increased in melanoma cell lines and in melanoma tumors in vivo. Src can activate STAT3, STAT5 and other downstream targets in melanoma. Src and STAT3 are expressed in their activated forms in both primary and metastatic melanoma in humans, although the expression level is variable. Cumulatively, these data mark Src signaling as attractive therapeutic targets in melanoma. Studies are currently underway with novel Src inhibitors in melanoma and in other tumor types.

Original languageEnglish (US)
Pages (from-to)91-100
Number of pages10
JournalExpert Opinion on Therapeutic Targets
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2007

Fingerprint

src-Family Kinases
Tumors
Melanoma
Cells
Neoplasms
Cell adhesion
Viruses
Rous sarcoma virus
Oncogenes
Cell Adhesion
Cell Movement
Carcinogenesis
Proteins
Cell Line

Keywords

  • Cancer
  • Melanoma
  • Src

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

The Src signaling pathway : A potential target in melanoma and other malignancies. / Homsi, Jade; Cubitt, Christopher; Daud, Adil.

In: Expert Opinion on Therapeutic Targets, Vol. 11, No. 1, 01.01.2007, p. 91-100.

Research output: Contribution to journalReview article

@article{203ce13a45b9400dbf3ff5f3c5c9845d,
title = "The Src signaling pathway: A potential target in melanoma and other malignancies",
abstract = "Although Src was the first oncogene to be discovered as the transforming protein of the Rous sarcoma virus almost three decades ago, the role of Src and the Src family kinases in human oncogenesis is still not completely understood. Recent studies have shown that Src regulates cell adhesion, invasiveness and motility in cancer cells and in tumor vasculature, rather than directly influencing cell replication. The role of the Src family kinases in human cancer is evolving and elevated levels of Src kinase activity have been reported in a number of human cancers in vitro and in vivo. Src expression and activity are increased in melanoma cell lines and in melanoma tumors in vivo. Src can activate STAT3, STAT5 and other downstream targets in melanoma. Src and STAT3 are expressed in their activated forms in both primary and metastatic melanoma in humans, although the expression level is variable. Cumulatively, these data mark Src signaling as attractive therapeutic targets in melanoma. Studies are currently underway with novel Src inhibitors in melanoma and in other tumor types.",
keywords = "Cancer, Melanoma, Src",
author = "Jade Homsi and Christopher Cubitt and Adil Daud",
year = "2007",
month = "1",
day = "1",
doi = "10.1517/14728222.11.1.91",
language = "English (US)",
volume = "11",
pages = "91--100",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - The Src signaling pathway

T2 - A potential target in melanoma and other malignancies

AU - Homsi, Jade

AU - Cubitt, Christopher

AU - Daud, Adil

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Although Src was the first oncogene to be discovered as the transforming protein of the Rous sarcoma virus almost three decades ago, the role of Src and the Src family kinases in human oncogenesis is still not completely understood. Recent studies have shown that Src regulates cell adhesion, invasiveness and motility in cancer cells and in tumor vasculature, rather than directly influencing cell replication. The role of the Src family kinases in human cancer is evolving and elevated levels of Src kinase activity have been reported in a number of human cancers in vitro and in vivo. Src expression and activity are increased in melanoma cell lines and in melanoma tumors in vivo. Src can activate STAT3, STAT5 and other downstream targets in melanoma. Src and STAT3 are expressed in their activated forms in both primary and metastatic melanoma in humans, although the expression level is variable. Cumulatively, these data mark Src signaling as attractive therapeutic targets in melanoma. Studies are currently underway with novel Src inhibitors in melanoma and in other tumor types.

AB - Although Src was the first oncogene to be discovered as the transforming protein of the Rous sarcoma virus almost three decades ago, the role of Src and the Src family kinases in human oncogenesis is still not completely understood. Recent studies have shown that Src regulates cell adhesion, invasiveness and motility in cancer cells and in tumor vasculature, rather than directly influencing cell replication. The role of the Src family kinases in human cancer is evolving and elevated levels of Src kinase activity have been reported in a number of human cancers in vitro and in vivo. Src expression and activity are increased in melanoma cell lines and in melanoma tumors in vivo. Src can activate STAT3, STAT5 and other downstream targets in melanoma. Src and STAT3 are expressed in their activated forms in both primary and metastatic melanoma in humans, although the expression level is variable. Cumulatively, these data mark Src signaling as attractive therapeutic targets in melanoma. Studies are currently underway with novel Src inhibitors in melanoma and in other tumor types.

KW - Cancer

KW - Melanoma

KW - Src

UR - http://www.scopus.com/inward/record.url?scp=33846261886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846261886&partnerID=8YFLogxK

U2 - 10.1517/14728222.11.1.91

DO - 10.1517/14728222.11.1.91

M3 - Review article

VL - 11

SP - 91

EP - 100

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 1

ER -